If weight loss is your main goal, talk to your provider about what to expect
Losing just 510 % of body weight has been shown to improve natural conception rates and IVF outcomes
References Varughese MS, OMahony F, Varadhan L (2025) GLP1 receptor agonist therapy and pregnancy: Evolving and emerging evidence
Maintaining basal-bolus GLP-1 levels as a treatment approach These studies have clearly shown that MBS corrects post-prandial GLP-1 responses in people with obesity but does not improve fasting GLP-1 levels, which remain lower in some patients as compared to normal-weight individuals
The version supplied by research peptide vendors is intended exclusively for laboratory and preclinical research use, not human consumption
In addition, preclinical studies have suggested that the peptide may have benefits related to its ability to boost both GH and its anabolic mediator insulin-like growth factor-1 (IGF-1)